DEFINITIVE PROXY STATEMENT

Company

TENAX THERAPEUTICS, INC.

Filed

September 6, 2011

Period of Report

September 30, 2011

Accession Number

0001354488-11-003237

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →